Cargando…
Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590291/ https://www.ncbi.nlm.nih.gov/pubmed/36264830 http://dx.doi.org/10.15585/mmwr.mm7142a3 |
| _version_ | 1784814481203789824 |
|---|---|
| author | Surie, Diya Bonnell, Levi Adams, Katherine Gaglani, Manjusha Ginde, Adit A. Douin, David J. Talbot, H. Keipp Casey, Jonathan D. Mohr, Nicholas M. Zepeski, Anne McNeal, Tresa Ghamande, Shekhar Gibbs, Kevin W. Files, D. Clark Hager, David N. Shehu, Arber Frosch, Anne P. Erickson, Heidi L. Gong, Michelle N. Mohamed, Amira Johnson, Nicholas J. Srinivasan, Vasisht Steingrub, Jay S. Peltan, Ithan D. Brown, Samuel M. Martin, Emily T. Khan, Akram Bender, William S. Duggal, Abhijit Wilson, Jennifer G. Qadir, Nida Chang, Steven Y. Mallow, Christopher Rivas, Carolina Kwon, Jennie H. Exline, Matthew C. Lauring, Adam S. Shapiro, Nathan I. Halasa, Natasha Chappell, James D. Grijalva, Carlos G. Rice, Todd W. Stubblefield, William B. Baughman, Adrienne Womack, Kelsey N. Hart, Kimberly W. Swan, Sydney A. Zhu, Yuwei DeCuir, Jennifer Tenforde, Mark W. Patel, Manish M. McMorrow, Meredith L. Self, Wesley H. Calhoun, Nicole Herrick, Judy Hoffman, Eric McKillop, Amanda Murthy, Kempapura Smith, Michael Zayed, Martha De Souza, Lesley Kozikowski, Lori-Ann Ouellette, Scott Ashok, Kiran Gole, Susan King, Alexander Mehkri, Omar Poynter, Bryan ten Lohuis, Caitlin Stanley, Nicholas Caspers, Sean Hendrickson, Audrey Kaus, Olivia Taghizadeh, Leyla Tordsen, Walker Aston, Valerie Bowers, Robert Jorgensen, Jeffrey King, Jennifer Ali, Harith Rothman, Richard E. Chen, Jen-Ting Nair, Rahul Allada, Gopal Briceno, Genesis Giovanni, Shewit Hubel, Kinsley A. Martinez, Jesus Oh, Minn Pak, Jonathan Pena, Jose Gordon, Alexandra Jun Levitt, Joe Perez, Cynthia Roque, Jonasel Visweswaran, Anita Karow, Sarah Khan, Maryiam Klingler, Austin Pannu, Sarah Smith, David Schwartz, Elizabeth Snyder, Connor So, Madison So, Preston Swoope, Gabrielle Weigand, Michael Carricato, Michael Chambers, Ian Driver, Conner Goff, Jennifer Huynh, David Jensen, Kelly Chandrasekaran, Sukantha Frankel, Trevor Garner, Omai Fairfield, Catherine Landers, Shannon Nassar, Paul Williams, Cameron Gershengorn, Hayley Bielak, Ramsay Blair, Christopher Fitzsimmons, William J. Fong, Rebecca Gilbert, Julie McSpadden, EJ Thomas, Lara Truscon, Rachel Valvano, Weronika Damek Anderson, Layla A. Crider, Christine D. Paulson, Thomas C. Steinbock, Kyle A. Blair, Marica Ezzell, Lauren J. Hargrave, Samarian J. Kampe, Christy Johnson, Jakea Luther, Jennifer L. McHenry, Rendie E. Peterson, Bryan P. M. Pulido, Claudia Guevara Short, Laura L. Whitsett, Margaret E. Hicks, Madeline Landreth, Leigha LaRose, Mary Parks, Lisa Babcock, Hilary Hink, Tiffany Jolani, Kevin McDonald, David O’Neal, Caroline Parikh, Bijal Parrish, Katie Samuels, Carleigh |
| author_facet | Surie, Diya Bonnell, Levi Adams, Katherine Gaglani, Manjusha Ginde, Adit A. Douin, David J. Talbot, H. Keipp Casey, Jonathan D. Mohr, Nicholas M. Zepeski, Anne McNeal, Tresa Ghamande, Shekhar Gibbs, Kevin W. Files, D. Clark Hager, David N. Shehu, Arber Frosch, Anne P. Erickson, Heidi L. Gong, Michelle N. Mohamed, Amira Johnson, Nicholas J. Srinivasan, Vasisht Steingrub, Jay S. Peltan, Ithan D. Brown, Samuel M. Martin, Emily T. Khan, Akram Bender, William S. Duggal, Abhijit Wilson, Jennifer G. Qadir, Nida Chang, Steven Y. Mallow, Christopher Rivas, Carolina Kwon, Jennie H. Exline, Matthew C. Lauring, Adam S. Shapiro, Nathan I. Halasa, Natasha Chappell, James D. Grijalva, Carlos G. Rice, Todd W. Stubblefield, William B. Baughman, Adrienne Womack, Kelsey N. Hart, Kimberly W. Swan, Sydney A. Zhu, Yuwei DeCuir, Jennifer Tenforde, Mark W. Patel, Manish M. McMorrow, Meredith L. Self, Wesley H. Calhoun, Nicole Herrick, Judy Hoffman, Eric McKillop, Amanda Murthy, Kempapura Smith, Michael Zayed, Martha De Souza, Lesley Kozikowski, Lori-Ann Ouellette, Scott Ashok, Kiran Gole, Susan King, Alexander Mehkri, Omar Poynter, Bryan ten Lohuis, Caitlin Stanley, Nicholas Caspers, Sean Hendrickson, Audrey Kaus, Olivia Taghizadeh, Leyla Tordsen, Walker Aston, Valerie Bowers, Robert Jorgensen, Jeffrey King, Jennifer Ali, Harith Rothman, Richard E. Chen, Jen-Ting Nair, Rahul Allada, Gopal Briceno, Genesis Giovanni, Shewit Hubel, Kinsley A. Martinez, Jesus Oh, Minn Pak, Jonathan Pena, Jose Gordon, Alexandra Jun Levitt, Joe Perez, Cynthia Roque, Jonasel Visweswaran, Anita Karow, Sarah Khan, Maryiam Klingler, Austin Pannu, Sarah Smith, David Schwartz, Elizabeth Snyder, Connor So, Madison So, Preston Swoope, Gabrielle Weigand, Michael Carricato, Michael Chambers, Ian Driver, Conner Goff, Jennifer Huynh, David Jensen, Kelly Chandrasekaran, Sukantha Frankel, Trevor Garner, Omai Fairfield, Catherine Landers, Shannon Nassar, Paul Williams, Cameron Gershengorn, Hayley Bielak, Ramsay Blair, Christopher Fitzsimmons, William J. Fong, Rebecca Gilbert, Julie McSpadden, EJ Thomas, Lara Truscon, Rachel Valvano, Weronika Damek Anderson, Layla A. Crider, Christine D. Paulson, Thomas C. Steinbock, Kyle A. Blair, Marica Ezzell, Lauren J. Hargrave, Samarian J. Kampe, Christy Johnson, Jakea Luther, Jennifer L. McHenry, Rendie E. Peterson, Bryan P. M. Pulido, Claudia Guevara Short, Laura L. Whitsett, Margaret E. Hicks, Madeline Landreth, Leigha LaRose, Mary Parks, Lisa Babcock, Hilary Hink, Tiffany Jolani, Kevin McDonald, David O’Neal, Caroline Parikh, Bijal Parrish, Katie Samuels, Carleigh |
| author_sort | Surie, Diya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9590291 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95902912022-10-31 Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 Surie, Diya Bonnell, Levi Adams, Katherine Gaglani, Manjusha Ginde, Adit A. Douin, David J. Talbot, H. Keipp Casey, Jonathan D. Mohr, Nicholas M. Zepeski, Anne McNeal, Tresa Ghamande, Shekhar Gibbs, Kevin W. Files, D. Clark Hager, David N. Shehu, Arber Frosch, Anne P. Erickson, Heidi L. Gong, Michelle N. Mohamed, Amira Johnson, Nicholas J. Srinivasan, Vasisht Steingrub, Jay S. Peltan, Ithan D. Brown, Samuel M. Martin, Emily T. Khan, Akram Bender, William S. Duggal, Abhijit Wilson, Jennifer G. Qadir, Nida Chang, Steven Y. Mallow, Christopher Rivas, Carolina Kwon, Jennie H. Exline, Matthew C. Lauring, Adam S. Shapiro, Nathan I. Halasa, Natasha Chappell, James D. Grijalva, Carlos G. Rice, Todd W. Stubblefield, William B. Baughman, Adrienne Womack, Kelsey N. Hart, Kimberly W. Swan, Sydney A. Zhu, Yuwei DeCuir, Jennifer Tenforde, Mark W. Patel, Manish M. McMorrow, Meredith L. Self, Wesley H. Calhoun, Nicole Herrick, Judy Hoffman, Eric McKillop, Amanda Murthy, Kempapura Smith, Michael Zayed, Martha De Souza, Lesley Kozikowski, Lori-Ann Ouellette, Scott Ashok, Kiran Gole, Susan King, Alexander Mehkri, Omar Poynter, Bryan ten Lohuis, Caitlin Stanley, Nicholas Caspers, Sean Hendrickson, Audrey Kaus, Olivia Taghizadeh, Leyla Tordsen, Walker Aston, Valerie Bowers, Robert Jorgensen, Jeffrey King, Jennifer Ali, Harith Rothman, Richard E. Chen, Jen-Ting Nair, Rahul Allada, Gopal Briceno, Genesis Giovanni, Shewit Hubel, Kinsley A. Martinez, Jesus Oh, Minn Pak, Jonathan Pena, Jose Gordon, Alexandra Jun Levitt, Joe Perez, Cynthia Roque, Jonasel Visweswaran, Anita Karow, Sarah Khan, Maryiam Klingler, Austin Pannu, Sarah Smith, David Schwartz, Elizabeth Snyder, Connor So, Madison So, Preston Swoope, Gabrielle Weigand, Michael Carricato, Michael Chambers, Ian Driver, Conner Goff, Jennifer Huynh, David Jensen, Kelly Chandrasekaran, Sukantha Frankel, Trevor Garner, Omai Fairfield, Catherine Landers, Shannon Nassar, Paul Williams, Cameron Gershengorn, Hayley Bielak, Ramsay Blair, Christopher Fitzsimmons, William J. Fong, Rebecca Gilbert, Julie McSpadden, EJ Thomas, Lara Truscon, Rachel Valvano, Weronika Damek Anderson, Layla A. Crider, Christine D. Paulson, Thomas C. Steinbock, Kyle A. Blair, Marica Ezzell, Lauren J. Hargrave, Samarian J. Kampe, Christy Johnson, Jakea Luther, Jennifer L. McHenry, Rendie E. Peterson, Bryan P. M. Pulido, Claudia Guevara Short, Laura L. Whitsett, Margaret E. Hicks, Madeline Landreth, Leigha LaRose, Mary Parks, Lisa Babcock, Hilary Hink, Tiffany Jolani, Kevin McDonald, David O’Neal, Caroline Parikh, Bijal Parrish, Katie Samuels, Carleigh MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-10-21 /pmc/articles/PMC9590291/ /pubmed/36264830 http://dx.doi.org/10.15585/mmwr.mm7142a3 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Surie, Diya Bonnell, Levi Adams, Katherine Gaglani, Manjusha Ginde, Adit A. Douin, David J. Talbot, H. Keipp Casey, Jonathan D. Mohr, Nicholas M. Zepeski, Anne McNeal, Tresa Ghamande, Shekhar Gibbs, Kevin W. Files, D. Clark Hager, David N. Shehu, Arber Frosch, Anne P. Erickson, Heidi L. Gong, Michelle N. Mohamed, Amira Johnson, Nicholas J. Srinivasan, Vasisht Steingrub, Jay S. Peltan, Ithan D. Brown, Samuel M. Martin, Emily T. Khan, Akram Bender, William S. Duggal, Abhijit Wilson, Jennifer G. Qadir, Nida Chang, Steven Y. Mallow, Christopher Rivas, Carolina Kwon, Jennie H. Exline, Matthew C. Lauring, Adam S. Shapiro, Nathan I. Halasa, Natasha Chappell, James D. Grijalva, Carlos G. Rice, Todd W. Stubblefield, William B. Baughman, Adrienne Womack, Kelsey N. Hart, Kimberly W. Swan, Sydney A. Zhu, Yuwei DeCuir, Jennifer Tenforde, Mark W. Patel, Manish M. McMorrow, Meredith L. Self, Wesley H. Calhoun, Nicole Herrick, Judy Hoffman, Eric McKillop, Amanda Murthy, Kempapura Smith, Michael Zayed, Martha De Souza, Lesley Kozikowski, Lori-Ann Ouellette, Scott Ashok, Kiran Gole, Susan King, Alexander Mehkri, Omar Poynter, Bryan ten Lohuis, Caitlin Stanley, Nicholas Caspers, Sean Hendrickson, Audrey Kaus, Olivia Taghizadeh, Leyla Tordsen, Walker Aston, Valerie Bowers, Robert Jorgensen, Jeffrey King, Jennifer Ali, Harith Rothman, Richard E. Chen, Jen-Ting Nair, Rahul Allada, Gopal Briceno, Genesis Giovanni, Shewit Hubel, Kinsley A. Martinez, Jesus Oh, Minn Pak, Jonathan Pena, Jose Gordon, Alexandra Jun Levitt, Joe Perez, Cynthia Roque, Jonasel Visweswaran, Anita Karow, Sarah Khan, Maryiam Klingler, Austin Pannu, Sarah Smith, David Schwartz, Elizabeth Snyder, Connor So, Madison So, Preston Swoope, Gabrielle Weigand, Michael Carricato, Michael Chambers, Ian Driver, Conner Goff, Jennifer Huynh, David Jensen, Kelly Chandrasekaran, Sukantha Frankel, Trevor Garner, Omai Fairfield, Catherine Landers, Shannon Nassar, Paul Williams, Cameron Gershengorn, Hayley Bielak, Ramsay Blair, Christopher Fitzsimmons, William J. Fong, Rebecca Gilbert, Julie McSpadden, EJ Thomas, Lara Truscon, Rachel Valvano, Weronika Damek Anderson, Layla A. Crider, Christine D. Paulson, Thomas C. Steinbock, Kyle A. Blair, Marica Ezzell, Lauren J. Hargrave, Samarian J. Kampe, Christy Johnson, Jakea Luther, Jennifer L. McHenry, Rendie E. Peterson, Bryan P. M. Pulido, Claudia Guevara Short, Laura L. Whitsett, Margaret E. Hicks, Madeline Landreth, Leigha LaRose, Mary Parks, Lisa Babcock, Hilary Hink, Tiffany Jolani, Kevin McDonald, David O’Neal, Caroline Parikh, Bijal Parrish, Katie Samuels, Carleigh Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title | Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title_full | Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title_fullStr | Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title_full_unstemmed | Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title_short | Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 |
| title_sort | effectiveness of monovalent mrna vaccines against covid-19–associated hospitalization among immunocompetent adults during ba.1/ba.2 and ba.4/ba.5 predominant periods of sars-cov-2 omicron variant in the united states — ivy network, 18 states, december 26, 2021–august 31, 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590291/ https://www.ncbi.nlm.nih.gov/pubmed/36264830 http://dx.doi.org/10.15585/mmwr.mm7142a3 |
| work_keys_str_mv | AT suriediya effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT bonnelllevi effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT adamskatherine effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gaglanimanjusha effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gindeadita effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT douindavidj effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT talbothkeipp effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT caseyjonathand effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mohrnicholasm effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT zepeskianne effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mcnealtresa effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ghamandeshekhar effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gibbskevinw effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT filesdclark effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hagerdavidn effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT shehuarber effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT froschannep effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ericksonheidil effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gongmichellen effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mohamedamira effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT johnsonnicholasj effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT srinivasanvasisht effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT steingrubjays effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT peltanithand effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT brownsamuelm effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT martinemilyt effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT khanakram effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT benderwilliams effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT duggalabhijit effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT wilsonjenniferg effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT qadirnida effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT changsteveny effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mallowchristopher effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT rivascarolina effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kwonjennieh effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT exlinematthewc effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT lauringadams effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT shapironathani effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT halasanatasha effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT chappelljamesd effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT grijalvacarlosg effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ricetoddw effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT stubblefieldwilliamb effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT baughmanadrienne effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT womackkelseyn effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hartkimberlyw effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT swansydneya effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT zhuyuwei effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT decuirjennifer effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT tenfordemarkw effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT patelmanishm effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mcmorrowmeredithl effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT selfwesleyh effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT calhounnicole effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT herrickjudy effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hoffmaneric effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mckillopamanda effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT murthykempapura effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT smithmichael effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT zayedmartha effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT desouzalesley effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kozikowskiloriann effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ouellettescott effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ashokkiran effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT golesusan effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kingalexander effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mehkriomar effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT poynterbryan effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT tenlohuiscaitlin effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT stanleynicholas effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT casperssean effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hendricksonaudrey effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kausolivia effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT taghizadehleyla effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT tordsenwalker effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT astonvalerie effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT bowersrobert effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT jorgensenjeffrey effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kingjennifer effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT aliharith effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT rothmanricharde effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT chenjenting effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT nairrahul effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT alladagopal effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT bricenogenesis effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT giovannishewit effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hubelkinsleya effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT martinezjesus effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ohminn effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT pakjonathan effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT penajose effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gordonalexandrajun effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT levittjoe effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT perezcynthia effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT roquejonasel effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT visweswarananita effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT karowsarah effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT khanmaryiam effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT klingleraustin effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT pannusarah effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT smithdavid effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT schwartzelizabeth effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT snyderconnor effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT somadison effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT sopreston effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT swoopegabrielle effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT weigandmichael effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT carricatomichael effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT chambersian effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT driverconner effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT goffjennifer effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT huynhdavid effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT jensenkelly effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT chandrasekaransukantha effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT frankeltrevor effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT garneromai effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT fairfieldcatherine effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT landersshannon effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT nassarpaul effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT williamscameron effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gershengornhayley effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT bielakramsay effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT blairchristopher effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT fitzsimmonswilliamj effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT fongrebecca effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT gilbertjulie effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mcspaddenej effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT thomaslara effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT trusconrachel effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT valvanoweronikadamek effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT andersonlaylaa effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT criderchristined effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT paulsonthomasc effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT steinbockkylea effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT blairmarica effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT ezzelllaurenj effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hargravesamarianj effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT kampechristy effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT johnsonjakea effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT lutherjenniferl effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mchenryrendiee effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT petersonbryanpm effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT pulidoclaudiaguevara effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT shortlaural effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT whitsettmargarete effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hicksmadeline effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT landrethleigha effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT larosemary effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT parkslisa effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT babcockhilary effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT hinktiffany effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT jolanikevin effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT mcdonalddavid effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT onealcaroline effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT parikhbijal effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT parrishkatie effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 AT samuelscarleigh effectivenessofmonovalentmrnavaccinesagainstcovid19associatedhospitalizationamongimmunocompetentadultsduringba1ba2andba4ba5predominantperiodsofsarscov2omicronvariantintheunitedstatesivynetwork18statesdecember262021august312022 |